Epigenetic Reprogramming in Early Mammalian Embryogenesis: Comparative Insights from Human and Model Systems
DOI:
https://doi.org/10.46966/msjar.v7i3.436Keywords:
DNA methylation, Epigenetic reprogramming , Human embryogenesis , Histone modificationsAbstract
Erasure and reinstatement of the epigenetic effects of totipotency and lineage specifications is the main event in early mammalian embryonic differentiation and entails epigenetic reprogramming. Two large-scale DNA demethylation waves of the world, global chromatin remodelling, histone dynamics of change, genomic imprint reinstatement, and X-chromosome reactivation, are also characteristic of it. Although our knowledge of the mechanics is largely based on the murine models, the growing availability of the single cell and multi omics technology has shown that there are species and conservation regulatory properties in human embryos. It may also be added that timing, maintenance of the imprint, access to the chromatin and control of transposable elements is also varied and this aspect explains why direct extrapolation cannot be carried out on human beings using the mouse models. In addition, the imprinting disorders have been linked to the epigenetic reprogramming perturbations and assisted reproductive technologies can have an effect on it. The provided review is a comparative examination in specifics of the epigenetic reprogramming in the first mammalian growth that attempts to discover the common mechanisms, species peculiarities, technological progress, and more recent clinical applications. Other questions/ directions that have not been addressed include translational reproductive medicine and epigenome editing.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Marwah A.K. Hameedi, Lubna Al-Anbari, Maha.F. Challab, Zainab Khalil Ismael, Ahmed Abdulkadhim Hamidy

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















